Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
63.5M
-
Shares change
-
-664K
-
Total reported value, excl. options
-
$714M
-
Value change
-
-$5.64M
-
Put/Call ratio
-
3.46
-
Number of buys
-
81
-
Number of sells
-
-47
-
Price
-
$11.21
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q3 2024
174 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2024.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.5M shares
.
Largest 10 shareholders include Deep Track Capital, LP (5.97M shares), BlackRock, Inc. (5.22M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.83M shares), FMR LLC (3.9M shares), VANGUARD GROUP INC (3.53M shares), Redmile Group, LLC (3.2M shares), Paradigm Biocapital Advisors LP (3.1M shares), Blue Owl Capital Holdings LP (3M shares), First Light Asset Management, LLC (2.58M shares), and TRV GP IV, LLC (2.13M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.